Skip to content
★ Sign in to follow
JN

John N. Bonfiglio

CEO
Marker Therapeutics, Inc.Harrow, Inc.Oragenics Inc
Total declarations
17
Companies
3
▲ Purchases (2 ops.)
€3,138
▼ Sales (0 ops.)
—

Latest filing published 13 Mar 2017 for Marker Therapeutics, Inc..

Insider track record

Disclosed buys
2
Disclosed sells
0
Signal history

No signal scores available.

Closed purchases

Market purchases
2

Not enough history yet: 0 closed purchases, at least 2 are needed.

Purchases by company

John N. Bonfiglio: trading record in brief

This profile gathers the share dealings of John N. Bonfiglio across 3 companies, led by Oragenics Inc, Marker Therapeutics, Inc. and Harrow, Inc. In total, 17 filings cover trades dated from 20 October 2010 to 9 March 2017.

Every open-market trade on record is a purchase: 2 purchases worth €3,138, and no sale. Unlike grants, an open-market purchase is paid for by the insider, at the market price. The rest of the record consists of 12 share grants and 1 option exercise.

The newest entry dates from 13 March 2017: a share grant, in Marker Therapeutics, Inc. The clock since the last published purchase (13 August 2014) now reads 4,471 days. Typically, a trade is published a median of 2 days after it takes place. Section 16 rules allow two business days to file each Form 4. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.

Companies and markets linked to John N. Bonfiglio

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations17 total

17 of 17 declarations